Related Experiment Videos
Photodynamic therapy for intracranial neoplasms. Literature review and institutional experience
T C Origitano1, M J Caron, O H Reichman
1Division of Neurological Surgery, Loyola University Medical Center, Maywood, IL 60153.
Abstract:
Primary malignant glial neoplasms of the central nervous system have a dismal 2-yr prognosis. An innovative approach to these formidable lesions is photodynamic therapy that employs a chemotherapeutic photosensitizing agent in combination with wavelength specific light to produce cytotoxic reactions capable of destroying neoplastic tissues. Animal and initial clinical studies of the application of photodynamic therapy to intracranial neoplasms have been promising. Parameters to optimize the efficacy of this treatment are under investigation. A review of the preclinical and clinical studies of photodynamic therapy for intracranial neoplasms is described.
Insights
Photodynamic therapy offers a promising new treatment for malignant glial neoplasms. This approach uses a photosensitizing agent and light to destroy brain tumors, showing potential in preclinical and clinical studies.
Area of Science:
- Oncology
- Neurosurgery
- Photochemistry
Background:
- Primary malignant glial neoplasms of the central nervous system have a poor prognosis.
- Current treatments for these brain tumors are limited.
- Photodynamic therapy (PDT) presents an innovative treatment strategy.
Purpose of the Study:
- To review preclinical and clinical studies of photodynamic therapy for intracranial neoplasms.
- To highlight the potential of PDT as a treatment for malignant glial tumors.
- To discuss ongoing investigations into optimizing PDT efficacy.
Main Methods:
- Review of existing scientific literature on photodynamic therapy for brain tumors.
- Analysis of preclinical animal studies.
- Evaluation of initial clinical trial data.
Main Results:
- Photodynamic therapy utilizes a photosensitizing agent and specific light wavelengths.
- This combination generates cytotoxic reactions to destroy neoplastic tissue.
- Animal and early clinical studies demonstrate promising outcomes for intracranial neoplasms.
Conclusions:
- Photodynamic therapy is a promising approach for treating malignant glial neoplasms.
- Further research is needed to optimize treatment parameters for maximum efficacy.
- PDT offers a novel therapeutic option for challenging brain tumors.